NEW YORK, July 26, 2007 — The Bank of New York Mellon, a global leader in asset management and securities servicing, has been selected by EastPharma Ltd. ("EastPharma") as depositary for its global depositary receipt (GDR) listing. Each EastPharma GDR represents one ordinary share. The GDRs trade on the London Stock Exchange under the symbol "EAST."

Incorporated in Bermuda, EastPharma is active in the manufacturing and marketing branded generics in Turkey. EastPharma's core businesses are the production and marketing of human pharmaceuticals, active pharmaceutical ingredients and veterinary products. These operations are complemented by the company's consumer goods business line, which includes empty ampoule and hygienic products manufacturing. EastPharma also seeks to acquire pharmaceutical companies in Turkey and selected emerging markets such as Russia.

Philipp Daniel Haas, chairman of EastPharma, said, "This is a significant transaction in our history and we are pleased with the success of the IPO. We look forward to working with The Bank of New York Mellon to maximize our program's performance and enable our investors to share in our long-term success."

Christopher Sturdy, executive vice president and head of The Bank of New York Mellon's Depositary Receipt Division, said, "Given our experience and expertise in the depositary receipts arena, we fully expect this program to elevate EastPharma's international profile and to allow it to pursue its strategic objectives."

The Bank of New York Mellon's Depositary Receipt business is conducted through The Bank of New York subsidiary, which acts as depositary for more than 1,270 American and global depositary receipt programs, acting in partnership with leading companies from 60 countries. With an unrivalled commitment to helping securities issuers succeed in the world's rapidly evolving financial markets, the Company delivers the industry's most comprehensive suite of integrated depositary receipt, corporate trust, and stock transfer services. Additional information is available at www.adrbny.com.

The Bank of New York Mellon Corporation is a global financial services company focused on helping clients manage and move their financial assets, operating in 37 countries and serving more than 100 markets. The company is a leading provider of financial services for institutions, corporations and high-net-worth individuals, providing superior asset management and wealth management, asset servicing, issuer services and treasury services through a worldwide client-focused team. It has more than $20 trillion in assets under custody and administration and more than $1 trillion in assets under management. Additional information is available at www.bnymellon.com.

The Bank of New York Mellon provides no advice nor recommendation or endorsement with respect to any company or security. Nothing herein shall be deemed to constitute an offer or solicitation of an offer to buy or sell securities.